Double layered hydroxides as potential anti-cancer drug delivery agents

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 4, 2013, Pages 522-529

  Riaz, Ufana ^a   Ashraf, S M ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Anti cancer agents; Cytotoxicity; Drug delivery; Layered double hydroxides; Nanomaterials

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CALCIUM PHOSPHATE; CAMPTOTHECIN; CARBON; CORDYCEPIN; DOUBLE LAYERED HYDROXIDE; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; GOLD; IRON OXIDE; METHOTREXATE; MONTMORILLONITE; SILICON DERIVATIVE; SILICON OXIDE; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; CHEMOTHERAPY; COLORECTAL CANCER; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DISSOLUTION; DRUG DELIVERY SYSTEM; HUMAN; NANOTECHNOLOGY; NEOPLASM; OSTEOSARCOMA CELL; OXIDATION; REVIEW; ZETA POTENTIAL;

EID: 84875294335     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313040005     Document Type: Review

References (63)

1. Duong, A.; Mousa, S. A. Current status of nucleoside antivirals in chronichepatitis B. Drugs Today (Barc) 2009, 45, 751-761.
2. Clifton, D. F.; Charles, R.J. Chemoradiation for anal cancer: The more things change, the more they stay the same. Oncology 2010, 24, 2-10.
3. Chen, E.X.; Siu, L.L. Development of molecular targeted anticancer agents: successes, failures and future directions. Curr. Pharm. Des. 2005, 11, 265-272.
4. Davis, D.W. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668. Clin. Cancer Res. 2005, 11, 678-689.
5. Wu, X.; Liu, H.; Liu, J.; Haley, K.N.; Treadway, J.A.; Larson, J.P. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol. 2003, 21, 41-46.
6. Yu, W.; Pirollo, K.F.;Yu, B.; Rait, A.; Xiang, L.;Huang, W. Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide. Nucleic Acids Res. 2004, 32, 41-48.
7. Farokhzad, O.C.; Jon, S.; Khademhosseini, A.; Tran, T.N.; Lavan, D.A.;Langer, R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 2004, 64, 7668-7672.
8. Kamb, A. Opinion: what's wrong with our cancer models? Nat Rev Drug Discov 2005, 4, 161-165.
9. Petri, F.A.; Chastellain, M.; Juillerat, J.L.; Ferrari, A.; Hofmann, H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 2005, 2, 2685-2694.
10. Keating, C.D. Nanoscience enables ultrasensitive detection of Alzheimer Ts biomarker. Proc. Natl. Acad. Sci. 2005, 102, 2263-2264.
11. Sahoo, S.K.; Labhasetwar, V. Nanotech approaches to drug delivery and imaging. Drug Discov. Today 2003, 8, 1112-1120.
12. Muller, R.H.; Keck, C.M. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. 2004, 113,151-170.
13. Koziara, J.M.; Lockman, P.R.; Allen, D.D.; Mumper, R.J. Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004, 99,259-269.
14. Hood, J.D.; Bednarski, M.; Frausto, R.; Guccione, S.; Reisfeld, R.A.; Xiang, R. Tumor regression by targeted gene delivery to the neovasculature. Science 2002, 296, 2404-2407.
15. Ding, X.; Alani, A.W.G.; Robinson, J.R. Extended-release and targeted drug delivery systems, In: Troy, D.B. (Ed.), Remington: The Science and Practice of Pharmacy, 21st Edition. Lippincott Williams & Wilkins, USA, pp. 939-964. Chap. 47, 2002.
16. Choy, J.H.; Kwak, S.Y.;Park, J.S.; Jeong, Y.J.; Portier, J. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J. Am. Chem. Soc. 1999,121, 1399-1400.
17. Lloyd., J.B.; Duncan, R.; Kopecek, J. Synthetic polymers as targetable carriers for drugs. Pure Appi. Chem. 1984, 56, 1301-1304.
18. Mirano, T.;Ohashi, S.; Morimoto, S.; Tsukada, K.; Kobayashi, T. and Tsukagoshi, S. Synthesis of antitumor-active conjugates of Adriamycin or daunomycin with the copolymer of divinyl ether and malcic anhydride. Makromol. Chem. 1986,187, 2815-2824,.
19. Oda, T.; Sato, F. and Maeda, H. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH. J. Nati. Cancer Inst., 1987, 79, 1205-1211.
20. Tsukada, V.; Matsumoto, S.; Hashida, M.; and Sezaki, H. Enhanced lymphatic delivery of mitomycin C conjugated with dextran. Cancer Res. 1984, 44, 2505-2510.
21. Hurwitz, E.; Wilchek, M.; Pitha. J. Soluble macromolecules as carriers for daunorubicin. J. Appi. Biochem. 1980, 2, 25-35.
22. Ouchi, T.; Yuyama, H.; Vogl, O. Synthesis of poly(ethyleneglycol)-bound 3-(5-fluorouracil-l-yl)propanoic acid, its hydrolysis reactivity and antitumor activity. Makromol. Chem. Rapid Commun.1985, 56, 815-819.
23. Hoes, C.J.T.; Potman, W.; Von Heeswijk, V.A.; Mud, R.J.; de Mooth, B.G.; Greve, J.; Feijen, J. Optimization of macromolecular prodrugs of the antitumor antibiotic adriamycin. J. Controlled Release, 1985, 2, 205-213.
24. Tsukada, Y.; Kato, Y.; Umemoto, N.;Takeda, Y.; HarÃ, T.; Hirai, H. An anti-i«-fetoprotein antibody-daunorubicin conjugate with a novel poly-i-glutamic acid derivative as intermediate drug carrier. J. Nati. Cancer Inst., 1984, 73, 721-729.
25. Pratesi, G.; Savi, G.; Pezzoni, G.; Bellini, O.; Penco, S.; Tinelli, S.; Zunino, F. Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug. Br.J. Cancer. 1985, 52, 841-848.
26. Supino, R.;Rribelli, N., and Zunino, F. Induction of differentiation of Friend murine erythroleukemia cells by poly-L-lysine and daunorubicin-poly-L-lysine conjugate. J. Nati. Cancer Inst., 1986, 77,453-457.
27. Ryser, H. J-P.; and Shen, W.C. Conjugation of mcthotrexate to poly(t.-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc. Nati. Acad. Sci. USA, 1978, 75, 3867-3870.
28. Theng, K.G. The Chemistry of Clay-Organic Reactions. Adam Hilger, London, UK, 1974.
29. Reichle, W.T. Synthesis of anionic clay minerals (mixed metal hydroxides, hydrotalcite). Solid State Ionics 1986, 22,135-141.
30. Cavani, F.; Trifiro, F.; Vaccari, A. Hydrotalcite-type anionic clays: Preparation, properties and applications. Catal. Today 1991, 11,173-301.
31. Ogawa, M.; Kuroda, K. Photofunctions of intercalation compounds. Chem. Rev. 1995, 95, 399-438.
32. Kim, S.S.; Zhang, W.Z.; Pinnavaia, T.J. Ultrastable mesostructured silica vesicles. Science 1998, 282 (5392),1302-1305.
33. Vaccari, A. Preparation and catalytic properties of cationic and anionic clays. Catal. Today 1998, 41, 53-71.
34. Robertson, R.H.S. Cadavers, chloreras and clays. Br. Miner. Soc. Bull. 1996, 113, 3-7.
35. Veniale, F.; Barberis, E.; Carcangiu, G.; Morandi, N.; Setti, M.; Tamanini, M.; Tessier, D. Formulation of muds for pelotherapy: effects of "maturation" by different mineral waters. Appl. Clay. Sci. 2004, 25, 135-148.
36. Abdel-Wahhab, M.A.; Nada, S.A.; Farag, I.M.; Abbas, N.F.; Amra, H.A. Potential protective effect of HSCAS and bentonite against dietary aflatoxicosis in rat: with special reference to chromosomal aberrations. Nat. Toxins 1998, 6, 211-218.
37. Ambrogi, V.; Fardella, G.; Grandolini, G.; Nocchetti, M.; Perioli, L. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble drugs. J. Pharm. Sci. 2003, 92, 1407-1418.
38. Castela-Papin, N.; Cai, S.; Vatier, J.; Keller, F.; Souleau, C.H.; Farinotti, R. Drug interaction with diosmectite: a study using the artificial stomach-duodenum model. Int. J. Pharm. 1999,182, 111-119.
39. Choy, J.H.; Kwak, S.Y.; Han, Y.S.; Kim, B.K. New organomontmorillonite complexes with hydrophobic and hydrophilic functions. Mater. Lett. 1997, 3, 143-147.
40. Gorchakov, V.N.; Dragun, G.N.; Kolmogorov, Y.P.; Smelova, V.A.; Tikhonova, L.I.; Tysjachnova, Y.V. The using of SR XRF for estimation of macro-and microelement contents of biological objects at the clay treatment. Nucl. Instrum. Methods Phys. Res. Sect. A Accel. Spectrom. Detect. Assoc. Equip. 2001, 470 (1-2), 437-440.
41. Choy, J.H.; Kwak, S.Y.; Park, J.S.; Jeong, Y.J.; Josik, P. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J. Am. Chem. Soc. 1999, 121, 1399-400.
42. Choy, J.H.; Kwak, S.Y.; Jeong, Y.J.; Park, J.S. Inorganic layered double hydroxides as nonviral vectors. Angew. Chem. Int. Ed 2000, 39, 4041-4045.
43. Khan, A.I.; Lei, L.; Norquist, A.J.; O'Hare, D. Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide. Chem. Commun. 2001, 22, 2342-2343.
44. Ambrogi, V.; Fardella, G.; Grandolini, G.; Perioli, L. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agent-I. Intercalation and in vitro release of ibuprofen. Int.J. Pharm. 2001, 220, 23-32.
45. Hwang, S.H.; Han, Y.S.; Choy, J.H. Intercalation of functional organic molecules with pharmaceutical cosmeceutical and nutraceutical functions into layered double hydroxides and zinc basicsalts. Bull. Korean. Chem. Soc. 2001, 22, 1019-1122.
46. Hussein, M.Z.; Zainal, Z.; Yahaya, A.H. Controlled release of a plant growth regulator, a-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite. J. Control Release 2002, 82, 417-427.
47. Braterman, P.S.; Xu, Z.P.; Yarberry F. In Handbook of Layered Materials, Auerbach S.M.; Carrado K.A.; Dutta P.K. (Eds.), pp. 373-474, Marcel Dekker, New York 2004.
48. Rives V. (Ed.). Layered Double Hydroxides: Present and Future, Nova Science Publishers, New York 2001.
49. Forano, C.; Hibino, T.; Leroux, F.; Taviot, G.C. Layered Double Hydroxides, Handbook of Clay Science Edited by F. Bergaya, B.K.G. Theng and G. Lagaly Developments in Clay Science, Elsevier Ltd. 2006.
50. Suresh, R.; Borkar, S.N.; Sawant, V.A.; Shende, V.S.; Dimble, S.K. Nanoclay Drug Delivery System Int.J. Pharm. Sci. Technol. 2010, 3(2), 901-905.
51. Oh, J.M.; Park, M.; Kim S.T.; Jung, J.Y.; Kang Y.G.; Choy J.H. Efficient delivery of anticancer drug MTX through MTX-LDH nanohybrid system. J. Phy. Chem. Solid, 2006, 67, 1024-1027.
52. Choy, J.H.; Jung, J.S.; Oh, J.M.; Park, M.; Jeong, J.; Kang, Y.K.; Han. O.J. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 2004, 25, 3059-3064.
53. Medina-Kauwe, L.K.; Xie, J.; Hamm, A.S. Intracellular trafficking of nonviral vectors. Gene Ther. 2005, 12, 1734-1751.
54. Kriven, W.M.; Kwak, S.Y.; Wallig, M.A.; Choy, J.H. Bioresorbable nanoceramics for gene and drug delivery. MRS Bulletin 2004, 29, 33-37.
55. Kwak, S.Y.; Kriven, W.M.; Wallig, M.A.; Choy, J.H. Inorganic delivery vector for intravenous injection. Biomaterials 2004, 25, 5995-6001.
56. Xu, Z.P.; Zeng, Q.H.; Lua, G.Q.; Yu, A.B. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem. Engg. Sci. 2006, (3), 1027-1040.
57. Tyner, K.M.; Roberson, M.S.; Berghorn, K.A.; Li, L.; Gilmour, R.F.; Batt, C.A.; Giannelis, E.P. Intercalation, delivery, and expression of the gene encoding green fluorescence protein utilizing nanobiohybrids. J. Control. Release 2004, 100, 399-409.
58. Tyner, K.M.; Schiffman, S.R.; Giannelis, E.P. Nanobiohybrids as delivery vehicles for camptothecin. J. Control. Release 2004, 95, 501-514.
59. Wang, Y.; Wang, E.; Gao, L.; Xu, L. Synthesis and properties of Mg2Al layered double hydroxides containing 5-fluorouracil J. Solid State Chem., 2005, 178, 736-741.
60. Ling, J.Y.; Yang, J.; Yang, Q.Z.; Peng, J.F.; Zhang, H.X.; Zhang, C.K. Study on Intercalative Nanohybrid of Cordycepin in Layered Double Hydroxide Chin. Chem. Lett. 2003, 14, 1097-1099.
61. Yang, Q.Z.; Yang, J.; Zhang, C.K. Layered Double Hydroxide as Cordycepin Delivery Nanocarrier Chin. Chem. Lett. 2006, 17, 985-987.
62. Lin, F.H.; Leeb, Y.H.; Jianb, C.H.; Wong, J.M.; Shieh, M.J.; Wang, C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier Biomaterials 2002,23,1981-1987
63. Pan, D.; Zhang, H.; Zhang, T.; Duan, X. A novel organic-inorganic microhybrids containing anticancer agent doxifluridine and layered double hydroxides: Structure and controlled release properties Chem. Engg. Sci. 2010, 65, 3763-3771.